Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.40 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.38 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL27670129 | 1.00 | ALDH1A1 (0.48) | ALDH1A1LMNAHSD17B10TP53ALOX15 | |
| Acetic Acid SCHEMBL4138880 | 1.00 | ALDH1A1 (0.48) | ALDH1A1LMNAHSD17B10TP53ALOX15 | |
| Hydrogen Peroxide SCHEMBL5367632 | 0.95 | ALDH1A1 (0.48) | ALDH1A1LMNAHSD17B10TP53ALOX15 | |
| Bicarbonate SCHEMBL28391088 | 0.92 | ALDH1A1 (0.46) | ALDH1A1LMNAHSD17B10TP53ALOX15 | |
| Acetone SCHEMBL3647744 | 0.92 | ALDH1A1 (0.50) | ALDH1A1LMNAHSD17B10TP53ALOX15 | |
| SCHEMBL471892 | 0.92 | ALDH1A1 (0.50) | ALDH1A1LMNAHSD17B10TP53ALOX15 | |
| SCHEMBL344175 | 0.92 | — | — | |
| SCHEMBL29615225 | 0.92 | — | — | |
| SCHEMBL22598 | 0.92 | — | — | |
| SCHEMBL284806 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115059456-A | Degradable radioactive isotope tracer and preparation method thereof | 河南省科学院同位素研究所有限责任公司 | 2022-09-16 | — | — | CN | claimed |
| CN-110831690-B | Film-forming solution and method for producing separation membrane using same | 株式会社大赛璐 | 2022-05-13 | — | — | CN | claimed |
| CN-103194349-A | Naked oat flavor type white wine and brewing method thereof | NINGXIAHONG CHINESE WOLFBERRY INDUSTRY GROUP CO LTD | 2013-07-10 | — | — | CN | claimed |
| EP-1091724-A4 | VASCULAR EMBOLIZING COMPOSITIONS COMPRISING ETHYL LACTATE AND METHODS FOR THEIR USE | MICRO THERAPEUTICS INC (US) | 2004-09-08 | — | — | EP | claimed |
| EP-1091724-A1 | VASCULAR EMBOLIZING COMPOSITIONS COMPRISING ETHYL LACTATE AND METHODS FOR THEIR USE | MICRO THERAPEUTICS, INC. (US) | 2001-04-18 | — | — | EP | claimed |
| US-6190646-B1 | AS BIODEGRADATION ACCELERATOR OF HYDROPHOBIC POLLUTANTS SUCH AS HYDROCARBONS | ELF AQUITAINE (FR) | 2001-02-20 | — | — | US | claimed |
| WO-2000001342-A1 | VASCULAR EMBOLIZING COMPOSITIONS COMPRISING ETHYL LACTATE AND METHODS FOR THEIR USE | MICRO THERAPEUTICS, INC. (US) | 2000-01-13 | — | — | WO | claimed |
| US-12620777-B2 | Optical member, laser module including said optical member, and laser device | DAICEL CORPORATION (JP) | 2026-05-05 | — | — | US | disclosed |
| EP-4700824-A1 | LOW-TEMPERATURE-SINTERING BONDING MATERIAL AND BONDED STRUCTURE | Daicel Corporation (JP) | 2026-02-25 | — | — | EP | disclosed |
| EP-4012726-B1 | ADHESIVE CONDUCTIVE PASTE | DAICEL CORP (JP) | 2025-10-22 | — | — | EP | disclosed |
| EP-4523625-A1 | ELECTRODE DEVICE FOR LIVING BODY | Toppan Holdings Inc. (JP) | 2025-03-19 | — | — | EP | disclosed |
| US-20250057457-A1 | ELECTRODE DEVICE FOR LIVING BODY | TOPPAN HOLDINGS INC. (JP) | 2025-02-20 | — | — | US | disclosed |
| US-12152169-B2 | Adhesive conductive paste | DAICEL CORPORATION (JP) | 2024-11-26 | — | — | US | disclosed |
| US-20100137515-A1 | PHOTO- AND/OR THERMO-CURABLE COPOLYMER, CURABLE RESIN COMPOSITIONS, AND CURED ARTICLES | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-06-03 | — | — | US | disclosed |
| EP-2147937-A1 | PHOTO- AND/OR THERMO-CURABLE COPOLYMER, CURABLE RESIN COMPOSITIONS, AND CURED ARTICLES | Daicel Chemical Industries, Ltd. (JP) | 2010-01-27 | — | — | EP | disclosed |
| US-6794108-B1 | COMPOUND CAPABLE OF GENERATING ACID BY ACTINIC RADIATION; POLYMER AND COMPOUND THAT DECOMPOSE TO A SULFONIC ACID; STORAGE STABILITY | FUJI PHOTO FILM CO., LTD. (JP) | 2004-09-21 | — | — | US | disclosed |
| CN-1269401-A | Wine mate and its production process and usage | TIANFU FAMOUS QUALITY WINE RES (CN) | 2000-10-11 | — | — | CN | disclosed |
| US-6051607-A | COMPRISING BIOCOMPATIBLE POLYMER, ETHYL LACTATE SOLVENT AND BIOCOMPATIBLE CONTRAST AGENT | MICRO THERAPEUTICS, INC. (US) | 2000-04-18 | — | — | US | disclosed |
| US-5677112-A | USING AN ANTHRACENE COMPOUND | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1997-10-14 | — | — | US | disclosed |
| US-5576359-A | ANTHRACENE DERIVATIVE, SOLVENT, COMPOUND CONTAINING GLYCIDYL GROUPS | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1996-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12620777-B2 | Optical member, laser module including said optical member, and laser device | MARK3, OR10J3, ILK | ALDH1A1 3032/4885LMNA 2730/4885HSD17B10 4701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.